SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hippieslayer who wrote (23255)7/15/1998 11:23:00 PM
From: jayhawk969  Read Replies (2) of 32384
 
Fugazi,
Did you read this article?

"Excluding the impact of a gain from sale of Ligand stock and certain one-time costs discussed below, diluted
earnings per share for the second quarter of 1998 were $0.54 compared to $0.33 for the second quarter of 1997.
During this quarter, Allergan initiated a program of liquidating its common stock holdings in Ligand
Pharmaceuticals Incorporated (Nasdaq: LGND - news). Allergan realized a pre-tax gain of $5.5 million, or $0.06
per share after tax, from the sale of the Ligand stock. Allergan intends to continue reducing its holdings of Ligand
common stock on a selective basis over the next several quarters."

I'll have to do some digging to see how many shares they still own.
Can sure tend to depress prices.

/
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext